ASH

Ashland Inc.

$76.81

-1.15%
SectorBasic MaterialsIndustrySpecialty ChemicalsCountryUnited States

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers.

Source: Yahoo Finance
AI summary

Price & performance

1M+3.1%
3M+4.3%
YTD+21.3%
1Y+49.8%
52-week range—
Beta0.99
Full chart and returns against a benchmark

Q-Score

48/ 100

Quality against peers; 50 is the peer median.

Growth48
Risk58
Performance42
Valuation54
Profitability50
Leverage54
Sentiment41
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$1.8B-13.7%
Net income-$845M-600.0%
Net margin-46.3%-54.3 pts
Historical fundamentals

Revenue exposure

75%of revenue from outside the US
Non Us75%
United States25%
Regions, segments, customers and suppliers

Valuation

ASHIndustryP/E67.6435.74P/S1.913.46EV/EBITDA13.5725.76P/B1.884.79PEG—1.57
Dividend yield2.16%
Every valuation metric

Earnings

Feb 1next report
EPS estimate$1.28
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate